Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies

August 24, 2023 | Comments Off on Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies

ESMO Open 2023 July 13 [Link] M V Dietz, J P van Kooten, M S Paats, J G V J Aerts, C Verhoef, E V E Madsen, H J Dubbink,…

Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma

August 23, 2023 | Comments Off on Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma

Frontiers in Toxicology 2023 June 27 [Link] Pooyeh Farahmand, Katarina Gyuraszova, Claire Rooney, Ximena L Raffo-Iraolagoitia, Geeshath Jayasekera, Ann Hedley, Emma Johnson, Tatyana Chernova, Gaurav Malviya, Holly Hall, Tiziana Monteverde,…

Malignant Pleural Mesothelioma (MPM) Presenting as Hydropneumothorax

August 22, 2023 | Comments Off on Malignant Pleural Mesothelioma (MPM) Presenting as Hydropneumothorax

Cureus 2023 July 1 [Link] Masami Kuramochi, Takuma Muraoka, Mayumi Shinonaga, Haruo Ohtani, Setsuo Kuraoka Abstract An 86-year-old man presented with bilateral lower limb edema and was found to have…

Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial

August 21, 2023 | Comments Off on Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial

Journal for Immunotherapy of Cancer 2023 August [Link] Michelle V Dietz, Katrien L A Quintelier, Job P van Kooten, Nadine L de Boer, Madelief Vink, Alexandra R M Brandt-Kerkhof, Cornelis…

Peritoneal papillary mesothelioma in situ: BAP1 mutation with indolent behavior for 15 years

August 18, 2023 | Comments Off on Peritoneal papillary mesothelioma in situ: BAP1 mutation with indolent behavior for 15 years

Virchows Archive 2023 July 10 [Link] Nikola Vitlarov, E Burtscher, E Pfeiffenberger, A Wahl, V Hodja, Z Jasarevic, K Kashofer, F A Offner Abstract Papillary mesothelioma in situ (PMIS) is…

Management of sarcomatoid Malignant pleural mesothelioma brain metastases with stereotactic radiosurgery: an Illustrative case

August 17, 2023 | Comments Off on Management of sarcomatoid Malignant pleural mesothelioma brain metastases with stereotactic radiosurgery: an Illustrative case

British Journal of Neurosurgery 2023 July 9 [Link] Jack K Donohue, Zhishuo Wei, Hansen Deng, Ajay Niranjan, L Dade Lunsford Abstract Background: Malignant pleural mesothelioma (MPM) is a rare cancer…

Gene fusions during the early evolution of mesothelioma correlate with impaired DNA repair and Hippo pathways

August 16, 2023 | Comments Off on Gene fusions during the early evolution of mesothelioma correlate with impaired DNA repair and Hippo pathways

Genes, Chromosomes, & Cancer 2023 July 8 [Link] Maymun Jama, Min Zhang, Charlotte Poile, Apostolos Nakas, Annabel Sharkey, Joanna Dzialo, Alan Dawson, Kudazyi Kutywayo, Dean A Fennell, Edward J Hollox…

An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration

August 15, 2023 | Comments Off on An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration

Journal of Cancer Research and Clinical Oncology 2023 July 8 [Link] Jiaxin Shi, Bo Peng, Xiang Zhou, Chenghao Wang, Ran Xu, Tong Lu, Xiaoyan Chang, Zhiping Shen, Kaiyu Wang, Chengyu…

Development of a prognostic nomogram for patients with malignant mesothelioma with bone metastasis

August 14, 2023 | Comments Off on Development of a prognostic nomogram for patients with malignant mesothelioma with bone metastasis

Scientific Reports 2023 July 4 [Link] Awen Yang, Bin Tang, Xuan Liu, Jingxuan He, Qun Yan, Xianghui Liang, Wenen Liu Abstract Malignant mesothelioma (MM) is a rare aggressive tumor, and…

Progranulin and EGFR modulate receptor-like tyrosine kinase sorting and stability in mesothelioma cells

August 11, 2023 | Comments Off on Progranulin and EGFR modulate receptor-like tyrosine kinase sorting and stability in mesothelioma cells

American Journal of Physiology. Cell Physiology 2023 August 1 [Link] Elisa Ventura, Antonino Belfiore, Renato V Iozzo, Antonio Giordano, Andrea Morrione Abstract Progranulin is a growth factor with pro-tumorigenic activity.…

Categories